World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

World Top Healthcare Companies in 2026
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.

  1. Kissei Pharmaceutical

    World Rank (Aug-2026)
    8,919
    Market Cap (Aug-2026)
    1.073 Billion USD
    World Rank (Jan-05-2024)
    8,738
    Market Cap (Jan-05-2024)
    0.971 Billion USD
    World Rank (Jul-30-2023)
    8,908
    Market Cap (Jul-30-2023)
    0.965 Billion USD
    World Rank (Dec-25-2022)
    8,901
    Market Cap (Dec-25-2022)
    0.906 Billion USD
    World Rank (Jan-07-2022)
    9,998
    Market Cap (Jan-07-2022)
    0.90 Billion USD
    Annual Revenue in USD
    477 Million USD
    Annual Net Income in USD
    94 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Japan
    Yahoo @ Tokyo
    Company Website
    KISSEI PHARMACEUTICAL
    Wikipedia
    Wikipedia

  2. POINT Biopharma Global Inc.

    World Rank (Aug-2026)
    8,923
    World Rank (Jan-05-2024)
    8,923
    World Rank (Jul-30-2023)
    8,923
    Market Cap (Jul-30-2023)
    0.962 Billion USD
    World Rank (Dec-25-2022)
    10,135
    Market Cap (Dec-25-2022)
    0.727 Billion USD
    World Rank (Jan-07-2022)
    13,170
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Annual Revenue in USD
    226 Million USD
    Annual Operating Income in USD
    125 Million USD
    Annual Net Income in USD
    98 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    POINT Biopharma Global Inc. is a Clinical Stage Global Pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. The headquarters is in USA.
    Company Website
    POINT BIOPHARMA GLOBAL INC.

  3. Gerresheimer AG

    World Rank (Aug-2026)
    8,938
    Market Cap (Aug-2026)
    1.068 Billion USD
    World Rank (Jan-05-2024)
    4,024
    Market Cap (Jan-05-2024)
    3.350 Billion USD
    World Rank (Jul-30-2023)
    3,467
    Market Cap (Jul-30-2023)
    4.113 Billion USD
    World Rank (Dec-25-2022)
    5,233
    Market Cap (Dec-25-2022)
    2.130 Billion USD
    World Rank (Jan-07-2022)
    5,029
    Market Cap (Jan-07-2022)
    2.85 Billion USD
    Annual Revenue in USD
    2,003 Million USD
    Annual Operating Income in USD
    241 Million USD
    Annual Net Income in USD
    106 Million USD
    Annual Results for Period Ending
    Nov-2022 ending year
    Headquarters Country
    Germany
    Yahoo @ Germany
    Company Profile

    GERRESHEIMER AG manufactures packaging materials needed to pack medicines and drugs to serve pharmaceutical companies. Headquarters is in Germany.

    Company Website
    GERRESHEIMER AG
    Wikipedia
    Wikipedia

  4. Wave Life Sciences

    World Rank (Aug-2026)
    8,951
    Market Cap (Aug-2026)
    1.066 Billion USD
    World Rank (Jan-05-2024)
    11,188
    Market Cap (Jan-05-2024)
    0.631 Billion USD
    World Rank (Jul-30-2023)
    14,083
    Market Cap (Jul-30-2023)
    0.403 Billion USD
    World Rank (Dec-25-2022)
    11,621
    Market Cap (Dec-25-2022)
    0.566 Billion USD
    World Rank (Jan-07-2022)
    19,803
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -122 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Singapore
    Yahoo @ Nasdaq
    Company Website
    WAVE LIFE SCIENCES LTD.

  5. Northeast Pharmaceutical Group

    World Rank (Aug-2026)
    8,962
    Market Cap (Aug-2026)
    1.064 Billion USD
    World Rank (Jan-05-2024)
    8,298
    Market Cap (Jan-05-2024)
    1.062 Billion USD
    World Rank (Jul-30-2023)
    8,381
    Market Cap (Jul-30-2023)
    1.076 Billion USD
    World Rank (Dec-25-2022)
    6,613
    Market Cap (Dec-25-2022)
    1.478 Billion USD
    World Rank (Jan-07-2022)
    8,260
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    NORTHEAST PHARMACEUTICAL GROUP

  6. Prevail Therapeutics

    World Rank (Aug-2026)
    8,965
    World Rank (Jan-05-2024)
    8,965
    World Rank (Jul-30-2023)
    8,965
    World Rank (Dec-25-2022)
    8,965
    World Rank (Jan-07-2022)
    8,965
    Headquarters Country
    USA
    Company Profile
    Prevail Therapeutics is a Clinical Stage Biotechnology company seeking to improve lives through the curative potential of gene therapy. The headquarters is in USA.
    Company Website
    PREVAIL THERAPEUTICS

  7. Sana Biotechnology Inc.

    World Rank (Aug-2026)
    8,966
    Market Cap (Aug-2026)
    1.063 Billion USD
    World Rank (Jan-05-2024)
    8,761
    Market Cap (Jan-05-2024)
    0.966 Billion USD
    World Rank (Jul-30-2023)
    8,207
    Market Cap (Jul-30-2023)
    1.115 Billion USD
    World Rank (Dec-25-2022)
    10,819
    Market Cap (Dec-25-2022)
    0.647 Billion USD
    World Rank (Jan-07-2022)
    5,595
    Market Cap (Jan-07-2022)
    2.40 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -269 Million USD
    Annual Net Income in USD
    -269 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SANA BIOTECHNOLOGY, INC.

  8. Brooklyn Immunotherapeutics Inc.

    World Rank (Aug-2026)
    8,971
    Market Cap (Aug-2026)
    1.063 Billion USD
    World Rank (Jan-05-2024)
    18,926
    World Rank (Jul-30-2023)
    18,926
    World Rank (Dec-25-2022)
    18,926
    World Rank (Jan-07-2022)
    18,926
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Headquarters Country
    USA
    Company Profile
    Brooklyn ImmunoTherapeutics is a Clinical Stage Biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. The company annual revenue is 5.8 million USD. The headquarters is in USA.
    Company Website
    BROOKLYN IMMUNOTHERAPEUTICS, INC.

  9. Green Cross Corporation

    World Rank (Aug-2026)
    8,977
    Market Cap (Aug-2026)
    1.060 Billion USD
    World Rank (Jan-05-2024)
    8,365
    Market Cap (Jan-05-2024)
    1.048 Billion USD
    World Rank (Jul-30-2023)
    8,787
    Market Cap (Jul-30-2023)
    0.991 Billion USD
    World Rank (Dec-25-2022)
    7,469
    Market Cap (Dec-25-2022)
    1.217 Billion USD
    World Rank (Jan-07-2022)
    6,341
    Market Cap (Jan-07-2022)
    1.97 Billion USD
    Annual Revenue in USD
    1,150 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    South Korea
    Yahoo @ SouthKorea
    Company Profile
    Green Cross Corporation is a biotechnology company focused on research, development and provision of a broad array of pharmaceutical products, medical devices and healthcare services for better global prevention, diagnosis and treatment of diseases of the body and mind. The company annual revenue is 1,537,825 million KRW and annual net income is 123,211 million KRW as on 2021. The headquarters is in South Korea.
    Company Website
    GREEN CROSS CORPORATION

  10. Avalo Therapeutics Inc.

    World Rank (Aug-2026)
    9,013
    Market Cap (Aug-2026)
    1.051 Billion USD
    World Rank (Jan-05-2024)
    31,979
    Market Cap (Jan-05-2024)
    0.007 Billion USD
    World Rank (Jul-30-2023)
    33,602
    Market Cap (Jul-30-2023)
    0.003 Billion USD
    World Rank (Dec-25-2022)
    25,537
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    21,658
    Market Cap (Jan-07-2022)
    0.12 Billion USD
    Headquarters Country
    USA
    Company Profile
    Avalo Therapeutics, Inc. is a biopharmaceutical company that discover, develop and commercialize highly targeted therapeutics in areas of significant unmet clinical need. The headquarters is in USA.
    Facts About Company
    Avalo Therapeutics, Inc. company annual revenue is 18 million USD and annual net loss -41 million USD as on Dec-2022.
    Company Website
    AVALO THERAPEUTICS, INC.

Share